Literature DB >> 10325242

Tissue-destructive macrophages in giant cell arteritis.

H L Rittner1, M Kaiser, A Brack, L I Szweda, J J Goronzy, C M Weyand.   

Abstract

Giant cell arteritis (GCA) is an inflammatory vasculopathy in which T cells and macrophages infiltrate the wall of medium and large arteries. Clinical consequences such as blindness and stroke are related to arterial occlusion. Formation of aortic aneurysms may result from necrosis of smooth muscle cells and fragmentation of elastic membranes. The molecular mechanisms of arterial wall injury in GCA are not understood. To identify mechanisms of arterial damage, gene expression in inflamed and unaffected temporal artery specimens was compared by differential display polymerase chain reaction. Genes differentially expressed in arterial lesions included 3 products encoded by the mitochondrial genome. Immunohistochemistry with antibodies specific for a 65-kDa mitochondrial antigen revealed that increased expression of mitochondrial products was characteristic of multinucleated giant cells and of CD68+ macrophages that cluster in the media and at the media-intima junction. 4-Hydroxy-2-nonenal adducts, products of lipid peroxidation, were detected on smooth muscle cells and on tissue infiltrating cells, in close proximity to multinucleated giant cells and CD68+ macrophages. Also, giant cells and macrophages with overexpression of mitochondrial products were able to synthesize metalloproteinase-2. Our data suggest that in the vascular lesions characteristic for GCA, a subset of macrophages has the potential to support several pathways of arterial injury, including the release of reactive oxygen species and the production of metalloproteinase-2. This macrophage subset is topographically defined and is also identified by overexpression of mitochondrial genes. Because these macrophages have a high potential to promote several mechanisms of arterial wall damage, they should be therapeutically targeted to prevent blood vessel destruction.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10325242     DOI: 10.1161/01.res.84.9.1050

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  40 in total

1.  Formation of new vasa vasorum in vasculitis. Production of angiogenic cytokines by multinucleated giant cells.

Authors:  M Kaiser; B Younge; J Björnsson; J J Goronzy; C M Weyand
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

Review 2.  [Pathogenesis of medium- and large-vessel vasculitis].

Authors:  C M Weyand; J J Goronzy
Journal:  Z Rheumatol       Date:  2009-03       Impact factor: 1.372

Review 3.  Immune checkpoint dysfunction in large and medium vessel vasculitis.

Authors:  Ryu Watanabe; Hui Zhang; Gerald Berry; Jörg J Goronzy; Cornelia M Weyand
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-03-17       Impact factor: 4.733

Review 4.  Macrophages in vascular inflammation--From atherosclerosis to vasculitis.

Authors:  Tsuyoshi Shirai; Marc Hilhorst; David G Harrison; Jörg J Goronzy; Cornelia M Weyand
Journal:  Autoimmunity       Date:  2015-03-26       Impact factor: 2.815

5.  Trapping of misdirected dendritic cells in the granulomatous lesions of giant cell arteritis.

Authors:  Wei Ma Krupa; Misha Dewan; Myung-Shin Jeon; Paul J Kurtin; Brian R Younge; Jörg J Goronzy; Cornelia M Weyand
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

Review 6.  Giant cell arteritis and polymyalgia rheumatica: current challenges and opportunities.

Authors:  Christian Dejaco; Elisabeth Brouwer; Justin C Mason; Frank Buttgereit; Eric L Matteson; Bhaskar Dasgupta
Journal:  Nat Rev Rheumatol       Date:  2017-09-14       Impact factor: 20.543

7.  An immunohistochemical analysis of folate receptor beta expression and distribution in giant cell arteritis - a pilot study.

Authors:  Shirley Albano-Aluquin; Jozef Malysz; Vincent R Aluquin; Manohar Ratnam; Nancy Olsen
Journal:  Am J Clin Exp Immunol       Date:  2017-12-20

8.  [Immunohistochemical detection of altered low density lipoprotein (ox-LDL) in the vessel walls of patients with giant cell arteritis].

Authors:  S C Beutelspacher; N Serbecic; F Tamaddon; M Mehrabi; H E Völcker
Journal:  Ophthalmologe       Date:  2003-11       Impact factor: 1.059

9.  Reactive nitrogen intermediates in giant cell arteritis: selective nitration of neocapillaries.

Authors:  Astrid Borkowski; Brian R Younge; Luke Szweda; Bettina Mock; Johannes Björnsson; Kerstin Moeller; Jörg J Goronzy; Cornelia M Weyand
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

Review 10.  The immunopathology of giant cell arteritis: diagnostic and therapeutic implications.

Authors:  Cornelia M Weyand; Y Joyce Liao; Jörg J Goronzy
Journal:  J Neuroophthalmol       Date:  2012-09       Impact factor: 3.042

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.